Bioinnovo and Algenex renew agreement for the use of APCH
In Uncategorized | No commentsBioinnovo, the technology-based public-private company formed by the National Institute of Agricultural Technology (INTA) and Vetanco SA, agree to renew their contract with Algenex for the use of the APCH molecule, the targeting protein of the innovative vaccine Vedevax BLOCK. After many years of successful…